Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1056/NEJMc2500500 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Magenta Elevate: The Beginning of a New Era in Protected PCI?
Artif Organs
March 2025
Department of Cardiothoracic Surgery, University of Texas Health at San Antonio, San Antonio, Texas, USA.
The Magenta Elevate (Magenta Medical Ltd.) pump-a novel transvalvular percutaneous ventricular assist device-was tested in the first-in-human study at the Israeli-Georgian Medical Research Clinic 'Helsicore' in Tbilisi, Georgia. Results on 14 patients undergoing high-risk percutaneous coronary intervention suggested a promising safety and efficacy profile.
View Article and Find Full Text PDFImpact of Post Percutaneous Coronary Intervention Fractional Flow Reserve on 5-Year Clinical Outcomes (The FFR SEARCH Study).
Catheter Cardiovasc Interv
March 2025
Department of (Interventional) Cardiology, Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands.
Background: Fractional flow reserve (FFR) following percutaneous coronary intervention (PCI) can be used to evaluate procedural success and to guide stent optimization. Several studies have demonstrated that lower FFR after stent implantation is associated with increased adverse event rates up to 2 years. However, the impact of post-PCI FFR on very long-term clinical outcome remains unknown.
View Article and Find Full Text PDFPredictive Value of the Naples Prognostic Score for One-Year Mortality in NSTEMI Patients Undergoing Selective PCI.
Diagnostics (Basel)
March 2025
Department of Emergency, Mamak State Hospital, 06100 Ankara, Turkey.
Non-ST-elevation myocardial infarction (NSTEMI) is a common and severe condition that requires rapid and accurate risk assessment and treatment. The Naples prognostic score (NPS) is a novel risk score that integrates nutritional and inflammatory parameters. The aim of this study was to investigate the NPS as a predictor of one-year mortality in NSTEMI patients undergoing percutaneous coronary intervention (PCI).
View Article and Find Full Text PDFTissue Doppler Imaging Provides Incremental Value in Predicting Six Months In-Stent Restenosis in Patients with Coronary Artery Disease.
Diagnostics (Basel)
February 2025
Department of Cardiology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan City 33305, Taiwan.
Invasive coronary angiography is the gold standard for assessing in-stent restenosis (ISR) in patients with coronary artery disease. However, the predictive value of non-invasive Tissue Doppler Imaging (TDI) to evaluate patients with ISR has not been studied extensively. A total of 41 patients (19 with acute myocardial infarction and 22 with stable angina pectoris) who received percutaneous coronary intervention (PCI) were enrolled in the study.
View Article and Find Full Text PDFResidual Tumour at CT Scan Based on Radiologic Peritoneal Carcinomatosis Index After Optimal Cytoreduction in Advanced Ovarian Cancer: A True Prognostic Factor.
Cancers (Basel)
February 2025
Department of Gynaecologic Oncology, University Hospital La Fe, 46026 Valencia, Spain.
Introduction: The maximum residual tumour size after surgery is the most important prognostic factor related to survival in advanced ovarian cancer. This parameter can be subjectively determined by the surgeon at the end of the operation and by a radiologist with a postoperative CT scan. CT scans after optimal cytoreduction can reveal residual/progressive disease in a significant percentage of patients, ranging from 21% to 49%.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!